Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 1, 2006, Pages

  Helle, Frank ^a,b   Vågnes, Øyvind B ^a   Iversen, Bjarne M ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

AT1aR; Calcium signaling physiology; Cyclooxygenase inhibitors; Fura 2; Indomethacin; NS 398; Receptors

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL MODEL; HYPERTENSION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

EID: 33745360875     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00279.2005     Document Type: Article

References (40)

1. Amiri F and Garcia R. Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats: effect of ACE inhibition. Hypertension 30: 337-344, 1997.
2. Bivol LM, Vagnes OB, and Iversen BM. The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 289: F393-F400, 2005.
3. Callera GE, Varanda WA, and Bendhack LM. Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors. Gen Pharmacol 34: 379-389, 2000.
4. Cervenka L, Horacek V, Vaneckova I, Hubacek JA, Oliverio MI, Coffman TM, and Navar LG. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 40: 735-741, 2002.
5. Cervenka L, Wang CT, Mitchell KD, and Navar LG. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 33: 102-107, 1999.
6. Cheng HF, Becker BN, Burns KD, and Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 95: 2012-2019, 1995.
7. Cheng HF and Harris RC. Cyclooxygenases, the kidney, and hypertension. Hypertension 43: 525-530, 2004.
8. Della Bruna R, Bernhard I, Gess B, Schricker K, and Kurtz A. Renin gene and angiotensin II AT1 receptor gene expression in the kidneys of normal and of two-kidney/one-clip rats. Pflügers Arch 430: 265-272, 1995.
9. Douglas JG and Hopfer U. Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu Rev Physiol 56: 649-669, 1994.
10. Haefliger JA, Bergonzelli G, Waeber G, Aubert JF, Nussberger J, Gavras H, Nicod P, and Waeber B. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. Hypertension 26: 733-737, 1995.
11. Hansen FH, Vagnes OB, and Iversen BM. Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat. Am J Physiol Renal Physiol 288: F1023-F1031, 2005.
12. Harris RC, Zhang MZ, and Cheng HF. Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand 181: 543-547, 2004.
13. Iversen BM and Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol Renal Physiol 274: F498-F508, 1998.
14. Iversen BM, Heyeraas KJ, Sekse I, Andersen KJ, and Ofstad J. Autoregulation of renal blood flow in two-kidney, one-clip hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 251: F245-F250, 1986.
15. Iversen BM, Kvam FI, Matre K, and Ofstad J. Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats. Am J Physiol Regul Integr Comp Physiol 275: R343-R349, 1998.
16. Iversen BM, Morkrid L, and Ofstad J. Afferent arteriolar diameter in DOCA-salt and two-kidney one-clip hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 245: F755-F762, 1983.
17. 2+ entry. Circ Res 87: 551-557, 2000.
18. McGiff JC and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol Regul Integr Comp Physiol 277: R607-R623, 1999.
19. Modrall JG, Quinones MJ, Frankhouse JH, Hsueh WA, Weaver FA, and Kedes L. Upregulation of angiotensin II type 1 receptor gene expression in chronic renovascular hypertension. J Surg Res 59: 135-140, 1995.
20. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
21. Navar LG, Harrison-Bernard LM, Nishiyama A, and Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002.
22. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
23. Navar LG and Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 13: 107-115, 2004.
24. Ogston AG. The spaces in a uniform random suspension of fibers. Faraday Soc Trans 54: 1754-1757, 1958.
25. Patzak A, Lai EY, Mrowka R, Steege A, Persson PB, and Persson AE. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int 66: 1949-1958, 2004.
26. Ploth DW. Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 245: F131-F141, 1983.
27. Ploth DW, Schnermann J, Dahlheim H, Hermle M, and Schmidmeier E. Autoregulation and tubuloglomerular feedback in normotensive and hypertensive rats. Kidney Int 12: 253-267, 1977.
28. Pluen A, Netti PA, Jain RK, and Berk DA. Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J 77: 542-552, 1999.
29. Purdy KE and Arendshorst WJ. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. Am J Physiol Renal Physiol 277: F850-F858, 1999.
30. Rao GN, Lassegue B, Alexander RW, and Griendling KK. Angiotensin II stimulates phosphorylation of high-molecular mass cytosolic phospholipase A2 in vascular smooth muscle cells. Biochem J 299: 197-201, 1994.
31. Ruan X, Wagner C, Chatziantoniou C, Kurtz A, and Arendshorst WJ. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 99: 1072-1081, 1997.
32. Rubanyi GM, Romero JC, and Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H1145-H1149, 1986.
33. Sadjadi J, Puttaparthi K, Welborn MB III, Rogers TE, Moe O, Clagett GP, Turnage RH, Levi M, and Modrall JG. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. J Vasc Surg 36: 386-392, 2002.
34. Schlondorff D. Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am J Med 81: 1-11, 1986.
35. Schlondorff D, DeCandido S, and Satriano JA. Angiotensin II stimulates phospholipases C and A2 in cultured rat mesangial cells. Am J Physiol Cell Physiol 253: C113-C120, 1987.
36. Schwietzer G and Gertz KH. Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats. Kidney Int 15: 134-143, 1979.
37. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Ozawa Y, and Saruta T. Role of nitric oxide and prostaglandin E2 in acute renal hypoperfusion. Nephrologie 8: 65-71, 2003.
38. Turkstra E, Braam B, and Koomans HA. Impaired renal blood flow autoregulation in two-kidney, one-clip hypertensive rats is caused by enhanced activity of nitric oxide. J Am Soc Nephrol 11: 847-855, 2000.
39. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, and Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol Cell Physiol 269: C1371-C1378, 1995.
40. Watanabe T, Barker TA, and Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension 45: 163-169, 2005.